Global Sanger Sequencing Market Size Projected to Reach $6.14 Billion During the Forecast Period

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Sanger Sequencing Market Over The Five-Year Period 2025–2029?

The sanger sequencing market has experienced swift growth in recent years. It is projected to increase from $2.75 billion in 2024 to $3.29 billion in 2025, maintaining a compound annual growth rate (CAGR) of 19.5%. The expansion witnessed historically can be linked to elevated research demand, an uptick in medical diagnostics, progress in pharmaceutical development, broader agricultural applications, more extensive forensic analysis, novel biomarker discoveries, and increased genetic evolution studies.

The sanger sequencing market is projected for substantial expansion in the coming years. This market is anticipated to reach “$6.14 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 16.9%. Factors contributing to this growth during the forecast period include the rising integration of clinical genomics, the expansion of agricultural genomics, enhanced drug safety and pharmacogenomics, greater prenatal and newborn screening, and the growing analysis of environmental DNA. Key trends anticipated for this period encompass technological progress, an escalating demand for next-generation sequencing, broadening applications in clinical diagnostics, increased investments in genomics research, and the wider adoption in personalized medicine.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13925&type=smp

Which Drivers Are Shaping The Sanger Sequencing Industry’s Market Share?

The expected increase in genetic illnesses is anticipated to drive the growth of the sanger sequencing market in the coming period. A genetic illness, or genetic disorder, is a medical condition stemming from abnormalities or mutations in an individual’s DNA, the hereditary material carrying genetic information. Sanger sequencing is utilized to diagnose genetic illnesses by determining the precise sequence of nucleotides (the fundamental units of DNA) in a specific gene or segment of DNA. For example, in August 2024, the National Health Service, a UK-based publicly funded healthcare system, indicated that approximately 2,300 individuals in the UK are living with thalassaemia as of 2024. Among these, around 800 have the severe version of the condition and rely on regular blood transfusions. Therefore, the rising incidence of genetic illness is a key factor propelling the sanger sequencing market.

How Is The Sanger Sequencing Market Segmented?

The sanger sequencingmarket covered in this report is segmented –

1) By Sequencing: Shotgun Sequencing; Targeted Gene Sequencing; Other Sequencing

2) By Laboratory: Wet Labs; Dry Labs

3) By Research: In-House; Outsourced

4) By Application: Diagnostics; Biomarkers and Cancer; Reproductive Health; Personalized Medicine; Forensics; Other Applications

5) By End User: Academic; Government Research Institutes; Pharmaceutical Companies; Biotechnology Companies; Hospitals; Clinics

Subsegments:

1) By Shotgun Sequencing: Whole Genome Shotgun Sequencing; Metagenomic Shotgun Sequencing

2) By Targeted Gene Sequencing: Amplicon Sequencing; Exome Sequencing

3) By Other Sequencing: Nested PCR Sequencing; Sequencing By Synthesis (SBS)

What Trends Are Redefining The Sanger Sequencing Market Dynamics?

Major companies operating in the sanger sequencing market are prioritizing the expansion of genomic laboratories to deliver rapid sanger sequencing services to the North of the UK. Genomic laboratories are specialized facilities dedicated to conducting genetic testing and analysis, aiming to understand the structure, function, and inheritance of genes and genomes, often for diagnostic, research, and personalized medicine objectives. For example, in June 2023, Source Genomics, a UK-based firm offering genomic services, announced the extension of its genomic laboratory into the UK’s north, which is projected to increase the capacity of their Sanger sequencing services and expedite data delivery turnaround times. Broadening laboratory operations into the northern territories represents a significant advancement in ensuring equitable access to genomic services for research organizations nationwide. This geographical development will allow clients across the country to benefit from high-quality Sanger sequencing services with quicker turnaround times.

Which Leading Companies Dominate The Sanger Sequencing Market Share?

Major companies operating in the sanger sequencing market report are Hoffmann-La Roche, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific, Illumina Inc., Beckman Coulter, PerkinElmer Inc., BGI Group, LGC Limited, GenScript, Oxford Nanopore Technologies, Pacific Biosciences of California Inc., Macrogen Inc., GENEWIZ Inc., Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty. Ltd., SciGenom Labs Pvt. Ltd., StarSEQ GmbH, GATC Biotech AG, Agilent Technologies

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/sanger-sequencing-global-market-report

What Regional Growth Trends Are Shaping The Sanger Sequencing Market Outlook?

North America was the largest region in the sanger sequencing market in 2024. The regions covered in the sanger sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Sanger Sequencing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13925&type=smp

Browse Through More Reports Similar to the Global Sanger Sequencing Market 2025, By The Business Research Company

Clinical Oncology Next Generation Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

Ngs Based Rna Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Prenatal Dna Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prenatal-dna-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795